CD8+ cytotoxic T lymphocytes are important effectors of anti-tumor immunity (Vesely et al., 2011; Abbas et al., 2018), and after the antigen presentation by DCs, successful stimulation of CD8+ T cells depends on the composition of these co-stimulatory factors such as cytokines and chemokines. The gene discussed is CD8A; the disease is neoplasm.